Drexler Karen

SEC source: 0001484612-26-000030 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,317

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001504699-26-000003 · form4-05082026_110516.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,211

Underlying: Common Stock · 34,211 shares

Expires 2036-05-05

F1 · derivative.exercise_date: 1/12 of the shares subject to the option shall vest on June 6, 2026 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001504699-26-000005 · form4a-07282026_090738.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,211

Underlying: Common Stock · 34,211 shares

Expires 2036-05-05

F1 · derivative.exercise_price: The original Form 4 filed May 8, 2026 has been amended to reflect the correct per share exercise price.

F2 · derivative.exercise_date: 1/12 of the shares subject to the option shall vest on June 6, 2026 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

SEC source: 0001484612-25-000081 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,650

SEC source: 0000943819-25-000174 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,602

F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.

SEC source: 0001484612-25-000053 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,198

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

F2 · balance_after: These numbers have been adjusted to reflect the 1-for-15 reverse stock split the Issuer effected on March 20, 2025 (the "Reverse Stock Split").

SEC source: 0001415889-25-014336 · form4-05232025_120536.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,781

Underlying: Common Stock · 175,781 shares

Expires 2035-03-17

F1 · derivative.exercise_price: The exercise price was determined and approved by the Board of Directors on March 18, 2025, subject to approval by the Company's stockholders at the 2025 annual meeting of stockholders (including any adjournment or postponement thereof) in accordance with the Listing Rules of the Australian Securities Exchange (ASX).

F2 · date: The Board of Directors approved the grant on March 18, 2025, subject to approval by the Company's stockholders at the 2025 annual meeting of stockholders (including any adjournment or postponement thereof) in accordance with the Listing Rules of the ASX.

F3 · derivative.exercise_date: The option vests in 1/12 equal monthly installments as measured from 5/21/2025, subject to continued employment or service through each such date.

SEC source: 0001484612-25-000036 · edgardoc.xml · derivative · entry 4

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Drexler Family Trust

Disclosed balance after: 0

Underlying: Preferred Stock · 125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

SEC source: 0001484612-25-000036 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Drexler Family Trust

Disclosed balance after: 31,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.

SEC source: 0001484612-25-000036 · edgardoc.xml · derivative · entry 3

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Drexler Family Trust

Disclosed balance after: 125

Underlying: Preferred Stock · 125 shares

Expires not disclosed

F2 · derivative.exercise_price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · price: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.exercise_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

F2 · derivative.expiration_date: These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.

SEC source: 0001127602-24-027903 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,529

F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date.

SEC source: 0000950170-24-096472 · ownership.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2034-08-08

F1 · derivative.exercise_date: The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date.

SEC source: 0001484612-24-000050 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,232

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001127602-24-013617 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,446

SEC source: 0001127602-23-028005 · form4.xml · derivative · entry 2

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,575

Underlying: ResMed Common Stock · 2,575 shares

Expires 2030-11-16

F2 · derivative.exercise_date: Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.

SEC source: 0001127602-23-028005 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,871

F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date.

SEC source: 0000899243-23-015786 · doc4.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-13

F1 · derivative.exercise_date: The option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date.

SEC source: 0001484612-23-000042 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,232

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001127602-23-003464 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,987

SEC source: 0001127602-22-026069 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,581

F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date.

SEC source: 0001104659-22-072045 · tm2218712-3_4seq1.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: The option vests as follows: (i) 50% one year from the grant date, and (ii) the remaining 50% in equal monthly installments over the next 24 months.

SEC source: 0001104659-22-073071 · tm2218957-2_4aseq1.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-06-13

F1 · derivative.exercise_date: This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on June 16, 2022 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect versting schedule being included for the option. As reflected in this Form 4/A, the option vests as follows: (i) 50% on the first anniversary of the grant date, (ii) 25% on the second anniversary of the grant date, and (iii) 25% on the third anniversary of the grant date.

SEC source: 0001484612-22-000053 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,551

F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0000899243-23-005056 · doc5.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Drexler Family Trust U/D/T dated May 23, 1996

Disclosed balance after: 18,076

F1 · kind: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity.

F1 · price: Represents a pro rata distribution from Astia Angels Tivic LLC, of which the reporting person was a member, in connection with the dissolution of such entity.

F2 · ownership.nature: These shares are owned directly by the Drexler Family Trust U/D/T dated May 23, 1996, and indirectly by the reporting person as trustee of such trust.

SEC source: 0001104659-21-150715 · tm2135733d5_4.xml · derivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2031-12-13

F1 · derivative.exercise_date: The option will vest one year from the grant date.

SEC source: 0000943819-21-000042 · primary_doc.xml · derivative · entry 2

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,695

Underlying: ResMed Common Stock · 1,695 shares

Expires 2028-11-18

F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.

SEC source: 0000943819-21-000042 · primary_doc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,459

F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2022, or the annual shareholder's meeting in the year following the grant date.

SEC source: 0001484612-21-000019 · edgardoc.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,671

F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

SEC source: 0001140361-21-000954 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,383

F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 08, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest quarterly over three years, subject to the reporting person's continuous service through the applicable vesting date.

SEC source: 0001127602-20-029768 · form4.xml · derivative · entry 2

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,265

Underlying: ResMed Common Stock · 2,265 shares

Expires 2027-11-19

F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date.

SEC source: 0001127602-20-029768 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,981

F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date.

SEC source: 0001127602-20-030208 · form4a.xml · derivative · entry 2

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,308

Underlying: ResMed Common Stock · 2,308 shares

Expires 2027-11-19

F1 · shares: Corrects original reported option grant for updated Black-Scholes valuation.

F1 · derivative.underlying_shares: Corrects original reported option grant for updated Black-Scholes valuation.

SEC source: 0001127602-20-030208 · form4a.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,981

SEC source: 0001127602-19-033703 · form4.xml · derivative · entry 2

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,889

Underlying: ResMed Common Stock · 3,889 shares

Expires 2026-11-21

F2 · derivative.exercise_date: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.

SEC source: 0001127602-19-033703 · form4.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,387

F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2020, or the annual shareholders meeting in the year following the grant date.

SEC source: 0001567619-19-005859 · doc1.xml · nonDerivative · entry 1

Drexler Karen · CIK 0001504699 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,524

F1 · date: Original filing was rejected for footnote error. Resubmission to correct the administrative error.

F2 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2019, or the annual shareholder's meeting in the year following the grant date.